The Food, Drug and Cosmetic Law Section of the New York State Bar Association is delving into the changing face of health law and regulations as part of its Annual Meeting taking place Jan. 14-17 at the New York Hilton Midtown.

FDA Commissioner, Dr. Robert M. Califf, announced before the November election that he would step down in 2025 regardless of who won the presidency. Our panel on Jan. 16 “FDA 2025: What to Expect After the Election” features three former senior FDA officials, who served in a variety of capacities. Eva Temkin, Michael Varrone and Maarika Kimbrell have experience in drug policy, evaluation and research in prior administrations.